Free shipping on all orders over $ 500

APTO-253

Cat. No. M13539
APTO-253 Structure
Synonym:

LOR-253; LT-253

Size Price Availability Quantity
5mg USD 100  USD100 In stock
10mg USD 150  USD150 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

APTO-253 (LOR-253) is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 mediates anticancer activity through induction of the Krüppel-like factor 4 (KLF4) tumor suppressor. APTO-253 has antiarthritic activity.

Chemical Information
Molecular Weight 367.38
CAS Number 916151-99-0
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Wataru Nakajima, et al. Genes (Basel). Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells

[2] Michael J Duffy, et al. Cancer Treat Rev. MYC as a target for cancer treatment

[3] Saikat Pal, et al. Phys Chem Chem Phys. An in silico investigation of the binding modes and pathway of APTO-253 on c-KIT G-quadruplex DNA

[4] Andrea Local, et al. Mol Cancer Ther. APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells

[5] Cheng-Yu Tsai, et al. Mol Cancer Ther. APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency

Related c-Myc Products
Omomyc

Omomyc is a cell-penetrating peptide derived from the bHLH structural domain of Myc. When expressed in cells, Omomyc inhibits C-Myc-mediated transcription and suppresses cell proliferation.Omomyc competes with C-Myc for binding to Max, resulting in the formation of the Omomyc/Max complex, which competes with the endogenous c-Myc/Max heterodimer and ultimately inhibits transcriptional activation resulting in Myc target genes involved in proliferation and metabolism.

MDEG-541

MDEG-541 is a potent MYC-MAX degrader.

c-Myc inhibitor 11

c-Myc inhibitor 11 is a c-MYC inhibitor (pEC50: 6.4).

c-Myc inhibitor 12

c-Myc inhibitor 12 is an inhibitor of c-Myc with a pEC50 of 6.4.

m-Se3

m-Se3 is a potent and selective c-MYC transcription inhibitor that can inhibit tumor growth and has anti-cancer activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: APTO-253, LOR-253; LT-253 supplier, c-Myc, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.